In last trading session, Summit Therapeutics Inc (NASDAQ:SMMT) saw 6.19 million shares changing hands with its beta currently measuring -1.05. Company’s recent per share price
Summit Therapeutics Inc (NASDAQ:SMMT) has a beta value of -0.94 and has seen 19.8 million shares traded in the last trading session. The company, currently
In the last trading session, 2.22 million shares of the Summit Therapeutics Inc (NASDAQ:SMMT) were traded, and its beta was -0.95. Most recently the company’s
Summit Therapeutics Inc (NASDAQ:SMMT)’s traded shares stood at 4.39 million during the last session, with the company’s beta value hitting -0.97. At the close of
In the last trading session, 1.65 million Summit Therapeutics Inc (NASDAQ:SMMT) shares changed hands as the company’s beta touched -0.99. With the company’s per share
Summit Therapeutics Inc (NASDAQ:SMMT) has a beta value of -0.96 and has seen 2.04 million shares traded in the last trading session. The company, currently
During the last session, Summit Therapeutics Inc (NASDAQ:SMMT)’s traded shares were 2.87 million, with the beta value of the company hitting -0.95. At the end
In the last trading session, 2.77 million shares of the Summit Therapeutics Inc (NASDAQ:SMMT) were traded, and its beta was -0.95. Most recently the company’s
In the last trading session, 7.35 million shares of the Summit Therapeutics Inc (NASDAQ:SMMT) were traded, and its beta was -0.94. Most recently the company’s
In the last trading session, 4.22 million Summit Therapeutics Inc (NASDAQ:SMMT) shares changed hands as the company’s beta touched -0.95. With the company’s per share
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne